Jeffrey A. Toretsky

10.2k total citations
121 papers, 6.9k citations indexed

About

Jeffrey A. Toretsky is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jeffrey A. Toretsky has authored 121 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 42 papers in Pulmonary and Respiratory Medicine and 30 papers in Oncology. Recurrent topics in Jeffrey A. Toretsky's work include Sarcoma Diagnosis and Treatment (38 papers), Protein Degradation and Inhibitors (19 papers) and RNA Research and Splicing (18 papers). Jeffrey A. Toretsky is often cited by papers focused on Sarcoma Diagnosis and Treatment (38 papers), Protein Degradation and Inhibitors (19 papers) and RNA Research and Splicing (18 papers). Jeffrey A. Toretsky collaborates with scholars based in United States, Austria and Türkiye. Jeffrey A. Toretsky's co-authors include Aykut Üren, Len Neckers, Lee J. Helman, Mikhail V. Blagosklonny, Hayriye V. Erkizan, Peter E. Wright, Ogan D. Abaan, Elspeth M. Beauchamp, Sean P. Bohen and Milton L. Brown and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Jeffrey A. Toretsky

119 papers receiving 6.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey A. Toretsky United States	46	4.7k	1.7k	1.7k	864	718	121	6.9k
Olle Larsson Sweden	51	4.4k 0.9×	2.2k 1.3×	2.5k 1.5×	1.3k 1.5×	654 0.9×	212	8.5k
Adrian Merlo Switzerland	46	5.8k 1.2×	1.1k 0.6×	2.8k 1.7×	1.9k 2.2×	498 0.7×	89	9.4k
Dale L. Ludwig United States	36	4.4k 0.9×	850 0.5×	1.6k 1.0×	993 1.1×	442 0.6×	91	5.9k
Svetlana Pack United States	47	3.1k 0.7×	1.4k 0.8×	1.5k 0.9×	1.1k 1.2×	308 0.4×	130	6.5k
Victor M. Rivera United States	47	4.9k 1.0×	1.7k 1.0×	2.0k 1.2×	560 0.6×	544 0.8×	162	8.3k
Tesshi Yamada Japan	50	4.3k 0.9×	2.0k 1.1×	2.7k 1.6×	1.3k 1.6×	1.0k 1.5×	141	8.3k
Katia Scotlandi Italy	55	5.0k 1.1×	3.6k 2.1×	2.8k 1.6×	2.2k 2.5×	504 0.7×	270	9.4k
Maria Flavia Di Renzo Italy	40	4.0k 0.9×	959 0.6×	1.9k 1.1×	995 1.2×	545 0.8×	106	7.4k
Aykut Üren United States	39	3.7k 0.8×	1.0k 0.6×	908 0.5×	554 0.6×	437 0.6×	126	5.1k
Laura E. Benjamin United States	38	6.9k 1.5×	1.2k 0.7×	2.6k 1.6×	2.8k 3.2×	1.1k 1.5×	70	10.8k

Countries citing papers authored by Jeffrey A. Toretsky

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Toretsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Toretsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Toretsky more than expected).

Fields of papers citing papers by Jeffrey A. Toretsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Toretsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Toretsky. The network helps show where Jeffrey A. Toretsky may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Toretsky

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Toretsky. A scholar is included among the top collaborators of Jeffrey A. Toretsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Toretsky. Jeffrey A. Toretsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyers, Paul A., Noah Federman, Najat C. Daw, et al.. (2024). Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. Journal of Clinical Oncology. 42(31). 3725–3734. 13 indexed citations

Song, Young, Purushottam B. Tiwari, Hsien-Chao Chou, et al.. (2023). Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity. Cancer Research Communications. 3(10). 2030–2043. 3 indexed citations

Kwon, Juntae, Min Soon Cho, Yifan Sun, et al.. (2021). Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response. Cancer Research. 81(13). 3607–3620. 40 indexed citations

Çelik, Haydar, et al.. (2021). Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells. PLoS ONE. 16(6). e0253170–e0253170. 5 indexed citations

Nosella, Michael L., Iva Pritišanac, P. Andrew Chong, et al.. (2021). O-Linked-N-Acetylglucosaminylation of the RNA-Binding Protein EWS N-Terminal Low Complexity Region Reduces Phase Separation and Enhances Condensate Dynamics. Journal of the American Chemical Society. 143(30). 11520–11534. 38 indexed citations

Zöllner, Stefan, James F. Amatruda, Sebastian Bauer, et al.. (2021). Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives. Journal of Clinical Medicine. 10(8). 1685–1685. 126 indexed citations

Ludwig, Joseph A., Noah Federman, Peter M. Anderson, et al.. (2020). 1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma. Annals of Oncology. 31. S972–S972. 10 indexed citations

Ma, Yan, Jennifer Crow, Vincent S. Staggs, et al.. (2019). Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis. Journal of Molecular Medicine. 97(7). 957–972. 21 indexed citations

Zöllner, Stefan, Saravana P. Selvanathan, Garrett T. Graham, et al.. (2017). Inhibition of the oncogenic fusion protein EWS-FLI1 causes G ₂ -M cell cycle arrest and enhanced vincristine sensitivity in Ewing’s sarcoma. Science Signaling. 10(499). 46 indexed citations

10.

Radic-Sarikas, Branka, Kalliopi P. Tsafou, Kristina B. Emdal, et al.. (2016). Combinatorial Drug Screening Identifies Ewing Sarcoma–specific Sensitivities. Molecular Cancer Therapeutics. 16(1). 88–101. 16 indexed citations

11.

Çelik, Haydar, Daisy D. Colón-López, Jenny Han, et al.. (2015). Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box. Molecular Cancer Therapeutics. 14(11). 2497–2507. 17 indexed citations

12.

Selvanathan, Saravana P., Garrett T. Graham, Hayriye V. Erkizan, et al.. (2015). Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proceedings of the National Academy of Sciences. 112(11). E1307–16. 105 indexed citations

13.

Shah, Nilay, Jianjun Wang, Garrett T. Graham, et al.. (2014). PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13- cis Retinoic Acid–Mediated Differentiation in Neuroblastoma. Clinical Cancer Research. 20(16). 4400–4412. 20 indexed citations

14.

Solomon, David A., Taeyeon Kim, Laura A. Díaz-Martínez, et al.. (2011). Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer. Science. 333(6045). 1039–1043. 311 indexed citations

15.

Beauchamp, Elspeth M., Lymor Ringer, Gülay Bulut, et al.. (2010). Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. Journal of Clinical Investigation. 121(1). 148–160. 274 indexed citations

16.

French, Christopher A., Cherie L. Ramirez, Tyler Hickman, et al.. (2007). BRD–NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 27(15). 2237–2242. 323 indexed citations

17.

Abaan, Ogan D., et al.. (2005). PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis. Oncogene. 24(16). 2715–2722. 60 indexed citations

18.

Üren, Aykut, Vladimir Wolf, Yufeng Sun, et al.. (2004). Wnt/Frizzled signaling in Ewing sarcoma. Pediatric Blood & Cancer. 43(3). 243–249. 53 indexed citations

19.

Toretsky, Jeffrey A., et al.. (2001). PBK/TOPK Is a Novel Mitotic Kinase Which Is Upregulated in Burkitt's Lymphoma and Other Highly Proliferative Malignant Cells. Blood Cells Molecules and Diseases. 27(5). 825–829. 97 indexed citations

20.

Toretsky, Jeffrey A., Len Neckers, & Leonard H. Wexler. (1995). Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors. JNCI Journal of the National Cancer Institute. 87(5). 385–386. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact